Novel Multiplex MethyLight Protocol for Detection of DNA Methylation in Patient Tissues and Bodily Fluids

Aberrant DNA methylation is a hallmark of cancer and is an important potential biomarker. Particularly, combined analysis of a panel of hypermethylated genes shows the most promising clinical performance. Herein, we developed, optimized and standardized a multiplex MethyLight assay to simultaneously...

Descripción completa

Detalles Bibliográficos
Autores principales: Olkhov-Mitsel, Ekaterina, Zdravic, Darko, Kron, Ken, van der Kwast, Theodorus, Fleshner, Neil, Bapat, Bharati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961737/
https://www.ncbi.nlm.nih.gov/pubmed/24651255
http://dx.doi.org/10.1038/srep04432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961737/
https://www.ncbi.nlm.nih.gov/pubmed/24651255
http://dx.doi.org/10.1038/srep04432

Ejemplares similares